Search research articles
Contact Us
Filters
Showing results (341-350 of 374) with videos related to
Page
of 38
Sort By:
Plos One
|
October 25, 2013
Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer
Xinyu Wu, Yirong Li, Jinhua Wang, et al.
Breast Cancer Research and Treatment
|
June 4, 2017
Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Jeffrey I Campbell, Christina Yau, Polina Krass, et al.
Journal of Cellular and Molecular Medicine
|
October 21, 2009
Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion
Yi Peng, Yirong Li, Lan Lin Gellert, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
October 8, 2025
Results of the international audit for faecal incontinence on behalf of the European Society of Coloproctology (ESCP) collaborating group
Audrius Dulskas, Dovile Cerkauskaite, Alaa El-Hussuna, et al.
The British Journal of Surgery
|
November 6, 2022
Managing surgical demand when needs outstrip resource: qualitative investigation of colorectal cancer surgery provision in the first wave of the COVID-19 pandemic
Carmel Conefrey, Cynthia Ochieng, Christin Hoffman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2002
Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses
Matthew Ellis, Natalie Davis, Andrew Coop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 6, 2014
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)
William M Sikov, Donald A Berry, Charles M Perou, et al.
American Journal of Cancer Research
|
July 25, 2014
Distinct breast cancer subtypes in women with early-onset disease across races
Mandeep Singh, Yi Ding, Li-Ying Zhang, et al.
Clinical Breast Cancer
|
January 18, 2016
Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy
Komal Jhaveri, Eleonora Teplinsky, Deborah Silvera, et al.
Cell Death & Disease
|
September 1, 2018
Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity
Ni Ni Moe Myint, Ajay M Verma, Daniel Fernandez-Garcia, et al.
Page
of 38
Search research articles
Search
Showing results (341-350 of 374) with videos related to
Sort By:
Page
of 38
Plos One
|
October 25, 2013
Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer
Xinyu Wu, Yirong Li, Jinhua Wang, et al.
Breast Cancer Research and Treatment
|
June 4, 2017
Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Jeffrey I Campbell, Christina Yau, Polina Krass, et al.
Journal of Cellular and Molecular Medicine
|
October 21, 2009
Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion
Yi Peng, Yirong Li, Lan Lin Gellert, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
October 8, 2025
Results of the international audit for faecal incontinence on behalf of the European Society of Coloproctology (ESCP) collaborating group
Audrius Dulskas, Dovile Cerkauskaite, Alaa El-Hussuna, et al.
The British Journal of Surgery
|
November 6, 2022
Managing surgical demand when needs outstrip resource: qualitative investigation of colorectal cancer surgery provision in the first wave of the COVID-19 pandemic
Carmel Conefrey, Cynthia Ochieng, Christin Hoffman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2002
Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses
Matthew Ellis, Natalie Davis, Andrew Coop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 6, 2014
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)
William M Sikov, Donald A Berry, Charles M Perou, et al.
American Journal of Cancer Research
|
July 25, 2014
Distinct breast cancer subtypes in women with early-onset disease across races
Mandeep Singh, Yi Ding, Li-Ying Zhang, et al.
Clinical Breast Cancer
|
January 18, 2016
Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy
Komal Jhaveri, Eleonora Teplinsky, Deborah Silvera, et al.
Cell Death & Disease
|
September 1, 2018
Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity
Ni Ni Moe Myint, Ajay M Verma, Daniel Fernandez-Garcia, et al.
Page
of 38